These findings are consistent with those of other studies, which demonstrated that UA’s anticancer activity involves downregulating the phosphorylation of Akt in oral, lung, ovarian, breast, prostate, and bladder cancer cells [18,20,21,27,28,82,83]. The gene discussed is AKT1; the disease is urinary bladder cancer.